Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization

Human Pathology

Volumn 33, Issue 6, 2002, Pages 632-641

  Hauptmann, Steffen ^a   Denkert, Carsten ^a   Koch, Ines ^a   Petersen, Simone ^a   Schluns, Karsten ^a   Reles, Angela ^a   Dietel, Manfred ^a   Petersen, Iver ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Borderline tumor; Chromosomal imbalance; Comparative genomic hybridization; Invasive carcinoma; Ovary

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 20; CHROMOSOME 20P; CHROMOSOME 21Q; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DATA BASE; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; OVARY TUMOR; PROGNOSIS; TUMOR LOCALIZATION;

EID: 0036329794     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.124913     Document Type: Article

References (54)

1. Cancer statistics
2. Toward the development of a universal grading system for ovarian epithelial carcinoma: Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up
3. Histological typing of ovarian tumors
4. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors
5. Characterization of a cell line derived from the ascites of a patient with papillary serous cystadenocarcinoma of the ovary
6. Image analysis for comparative genomic hybridization by a Windows-based karyotyping program
7. A t-statistic for objective interpretation of comparative genomic hybridization (CGH) profiles
8. Distinction of low-grade from high-grade ovarian cacinomas on the basis of losses of heterozygosity on chromosomes 3, 6 and 11 and HER-2/neu gene amplification
9. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor
10. Genetic analysis of benign, low-grade, and high-grade ovarian tumors
11. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases
12. Comparative genomic hybridization: A comparison with molecular and cytogenetic analysis
13. Overrepresentation of 3q and 8q material are recurrent findings in advanced human ovarian cancer
14. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas
15. Comparative genomic hybridization detects frequent overexpression of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas
16. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization
17. Karyotypic analysis of 32 epithelial ovarian tumors
18. Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation
19. Serous tumors of low malignant potential (SLMP) of the ovary - Molecular pathology (part 2 of 2)
20. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors
21. Chromosomal aberrations in 35 primary ovarian carcinomas
22. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumors
23. Chromosome aberrations in metastatic ovarian cancer: Relationship with abnormalities in primary tumors
24. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: Extensive similarity except for a difference at chromosome 2q24-q32
25. Loss of hcterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22
26. A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity
27. Identification of FAP locus genes from chromosome 5q21
28. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton
29. Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14
30. Karyotypic analysis of human ovarian carcinoma cells cloned in short-term agar culture
31. Chromosome aberrations in nine patients with ovarian cancer
32. Abnormal chromosomes including small metacentrics in 14 ovarian cancers
33. Prevalence and clinical significance of cytogenetic abnormalities in human ovarian cancer
34. Human epithelial ovarian cancer allelotype
35. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer
36. Allelotype of human ovarian cancer
37. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma
38. Early involvement of 6q in surface epithelial ovarian tumors
39. Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2cM fragment in chromosomal region 6q24-q25
40. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas
41. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapotosis
42. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway
43. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21
44. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors
45. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus
46. DPC4 gene in various tumor types
47. Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers
48. Loss of DCC gene expression during ovarian tumorigenesis: Relation to tumour differentiation and progression
49. Allelic loss on chromosome 17 in human ovarian cancer
50. Allele loss from chromosome 17 in ovarian cancer
51. Genetic alterations distinguish between different types of ovarian tumors
52. Molecular genetics of epithelial ovarian neoplasms: Correlations with phenotype and biological behavior
53. Genetic instability in human ovarian cancer cell lines